Anbio Biotechnology (NNNN)

Profile

Full Name

Anbio Biotechnology

Ticker

NASDAQ: NNNN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Germany

IPO

February 19, 2025

Indexes

Not included

Website

https://www.anbio.com

Employees

27

Key Details

Price

$49.86(+0.95%)

Market cap

$2.19B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$8.85M(+22.01% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

Aug 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $49.86
    NNNN price is $49.86

    30-Day Relative Volume

    0.73
    NNNN 30-day relative volume is 0.73

    Price Performance

    Price Most recent change

    +0.95%
    NNNN price was up +0.95% on Aug 22, 2025

    Price YTD change

    -
    NNNN price ytd change is unknown

    Price 1-year change

    -
    NNNN price 1-year change is unknown

    Price 3-year change

    -
    NNNN price 3-year change is unknown

    Price Range

    Price All-time high

    $55.65
    NNNN price is currently -10.40% below its historical high of $55.65

    Price 3-year low

    $5.18
    NNNN price is currently +862.55% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.19B
    NNNN market capitalization is $2.19 billion

    Market cap 3-year change

    -
    NNNN market capitalization 3-year change is unknown

    Market cap All-time high

    $2.29B
    NNNN market capitalization is currently -4.30% below its historical high of $2.29 billion

    Market cap sector rank

    82.21%
    NNNN market capitalization is higher than 82.21% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    NNNN shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    -
    NNNN shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.23
    NNNN beta is 0.23

    200-day SMA

    $19.80
    NNNN price is currently +151.79% above its 200-day simple moving average

    50-day SMA

    $39.97
    NNNN price is currently +24.73% above its 50-day simple moving average

    RSI

    57.67
    NNNN 14-day relative strength index is 57.67

    Volume

    0.73
    NNNN 30-day relative volume is 0.73

    ATR

    $4.41
    NNNN average true range is $4.41

    10-day Historical Volatility

    52.41%
    NNNN 10-day historical volatility is 52.41%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $8.85M
    NNNN annual revenue is $8.85 million

    Revenue Analysts estimate

    -
    NNNN annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +22.01%
    NNNN annual revenue is up +22.01% year-on-year

    Revenue Sector rank

    46.82%
    NNNN annual revenue is higher than 46.82% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    NNNN annual earnings per share is $0.00

    EPS Analysts estimate

    -
    NNNN annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    0%
    NNNN annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    82.53%
    NNNN annual earnings per share is higher than 82.53% of companies in Healthcare sector

    Profit

    Gross profit

    $5.89M
    NNNN annual gross profit is $5.89 million

    Gross margin

    71.90%
    NNNN annual gross profit margin is 71.90%

    Operating profit

    $2.00M
    NNNN annual operating income is $2.00 million

    Operating margin

    24.38%
    NNNN annual operating profit margin is 24.38%

    Net income

    $2.57M
    NNNN annual net profit is $2.57 million

    Net margin

    28.99%
    NNNN annual net profit margin is 28.99%

    Expenses

    Total expenses

    $6.19M
    NNNN annual total expenses is $6.19 million

    Operating expenses

    $3.89M
    NNNN annual total operating expenses is $3.89 million

    Cost of goods sold

    $2.30M
    NNNN annual cost of goods sold is $2.30 million

    Selling, general & administrative expenses

    $3.44M
    NNNN annual SGA is $3.44 million

    Depreciation and amortization

    $0.00
    NNNN annual depreciation & amortization is $0.00

    Interest expense

    $0.00
    NNNN annual interest expense is $0.00

    Income tax

    $0.00
    NNNN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    $2.37M
    NNNN annual earnings before interest & taxes is $2.37 million

    EBITDA

    $2.37M
    NNNN annual EBITDA is $2.37 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $19.59M
    NNNN annual total assets is $19.59 million

    Non current assets

    $387.40K
    NNNN annual long term assets is $387.40 thousand

    Current assets

    $18.53M
    NNNN annual total current assets is $18.53 million

    Cash and cash equivalents

    $11.76M
    NNNN annual cash & cash equivalents is $11.76 million

    Accounts receivable

    $1.06M
    NNNN annual accounts receivable is $1.06 million

    Inventory

    $0.00
    NNNN annual inventory is $0.00

    Liabilities

    Total liabilities

    $1.79M
    NNNN annual total liabilities is $1.79 million

    Long term liabilities

    $0.00
    NNNN annual total long term liabilities is $0.00

    Current liabilities

    $1.73M
    NNNN annual total current liabilities is $1.73 million

    Accounts payable

    $1.63M
    NNNN annual accounts payable is $1.63 million

    Debt

    Total debt

    $0.00
    NNNN annual total debt is $0.00

    Total debt 1-year change

    0%
    NNNN annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    NNNN annual long term debt is $0.00

    Short term debt

    $0.00
    NNNN annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $17.80M
    NNNN annual stockholders equity is $17.80 million

    Book value

    $17.19M
    NNNN annual book value is $17.19 million

    Retained earnings

    $17.17M
    NNNN annual retained earnings is $17.17 million

    Working capital

    $16.80M
    NNNN annual working capital is $16.80 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $2.08M
    NNNN annual cash flow from operations is $2.08 million

    Cash from operations 1-year change

    +131.57%
    NNNN annual cash flow from operations is up +131.57% year-on-year

    Cash from investing

    $337.10K
    NNNN annual cash flow from investing activities is $337.10 thousand

    Cash from investing 1-year change

    -80.52%
    NNNN annual cash flow from investing activities is down -80.52% year-on-year

    Cash from financing

    -$372.80K
    NNNN annual cash flow from financing activities is -$372.80 thousand

    Cash from financing 1-year change

    -705.18%
    NNNN annual cash flow from financing activities is down -705.18% year-on-year

    CAPEX

    CAPEX

    $0.00
    NNNN annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    NNNN annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    $2.08M
    NNNN annual free cash flow is $2.08 million

    Free cash flow 1-year change

    +131.57%
    NNNN annual free cash flow is up +131.57% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    71.90%
    NNNN annual gross profit margin is 71.90%

    Operating margin

    24.38%
    NNNN annual operating profit margin is 24.38%

    Net margin

    28.99%
    NNNN annual net profit margin is 28.99%

    ROA & ROE

    ROA

    13.85%
    NNNN annual return on assets is 13.85%

    ROE

    15.02%
    NNNN annual return on equity is 15.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NNNN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NNNN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    127.30
    NNNN price to book ratio is 127.30

    PB ratio Sector rank

    99.25%
    NNNN price to book ratio is higher than 99.25% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    NNNN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    NNNN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $2.18B
    NNNN enterprise value is $2.18 billion

    Enterprise value Sector rank

    82.09%
    NNNN enterprise value is higher than 82.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    NNNN EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    NNNN EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.71
    NNNN annual current ratio is 10.71

    Quick ratio

    10.71
    NNNN annual quick ratio is 10.71

    Leverage

    Debt to equity

    0.00
    NNNN annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    NNNN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    NNNN piotroski f-score value is unknown

    Altman Z-Score

    735.96
    NNNN altman z-score is 735.96

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with NNNN included

    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Mid cap stocks
    Healthcare sector
    All stocks
    High Altman Z score stocks
    Earnings next week
    NASDAQ Listed Companies
    Best performing stocks last month
    Ex Dividend dates calendar
    • What is the ticker symbol for Anbio Biotechnology?
    • Does Anbio Biotechnology pay dividends?
    • What sector is Anbio Biotechnology in?
    • What industry is Anbio Biotechnology in?
    • What country is Anbio Biotechnology based in?
    • When did Anbio Biotechnology go public?
    • Is Anbio Biotechnology in the S&P 500?
    • Is Anbio Biotechnology in the NASDAQ 100?
    • Is Anbio Biotechnology in the Dow Jones?
    • When was Anbio Biotechnology's last earnings report?
    • When does Anbio Biotechnology report earnings?

    What is the ticker symbol for Anbio Biotechnology?

    The ticker symbol for Anbio Biotechnology is NASDAQ:NNNN

    Does Anbio Biotechnology pay dividends?

    No, Anbio Biotechnology does not pay dividends

    What sector is Anbio Biotechnology in?

    Anbio Biotechnology is in the Healthcare sector

    What industry is Anbio Biotechnology in?

    Anbio Biotechnology is in the Medical Instruments & Supplies industry

    What country is Anbio Biotechnology based in?

    Anbio Biotechnology is headquartered in Germany

    When did Anbio Biotechnology go public?

    Anbio Biotechnology's initial public offering (IPO) was on February 19, 2025

    Is Anbio Biotechnology in the S&P 500?

    No, Anbio Biotechnology is not included in the S&P 500 index

    Is Anbio Biotechnology in the NASDAQ 100?

    No, Anbio Biotechnology is not included in the NASDAQ 100 index

    Is Anbio Biotechnology in the Dow Jones?

    No, Anbio Biotechnology is not included in the Dow Jones index

    When was Anbio Biotechnology's last earnings report?

    Anbio Biotechnology's most recent earnings report was on August 21, 2025

    When does Anbio Biotechnology report earnings?

    The next expected earnings date for Anbio Biotechnology is August 28, 2025
    On this page